1-9 of 9
Donald L. Trump
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors

Marwan G. Fakih, Donald L. Trump, Josephia R. Muindi, Jennifer D. Black, Ronald J. Bernardi, Patrick J. Creaven, James Schwartz, Michael G. Brattain, Alan Hutson, Renee French, Candace S. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1216–1223.
https://doi.org/10.1158/1078-0432.CCR-06-1165
Published: 22 February 2007
View article titled, A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors
Open the PDF for A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors in another window
Journal Articles

Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer

Tomasz M. Beer, Milind Javle, Gilbert N. Lam, W. David Henner, Alvin Wong, Donald L. Trump
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7794–7799.
https://doi.org/10.1158/1078-0432.CCR-05-0552
Published: 08 November 2005
View article titled, Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer
Open the PDF for Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer in another window
Journal Articles

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Donald L. Trump, Julie L. Eiseman, Chandra P. Belani, Sanjiv S. Agarwala, Eleanor G. Zuhowski, Jing Lan, Douglas M. Potter, S. Percy Ivy, Sakkaraiappan Ramalingam, Adam M. Brufsky, Michael K.K. Wong, Susan Tutchko, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3385–3391.
https://doi.org/10.1158/1078-0432.CCR-04-2322
Published: 02 May 2005
View article titled, Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers
Open the PDF for Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers in another window
Journal Articles

Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors

William C. Zamboni, Laura L. Jung, Merrill J. Egorin, Douglas M. Potter, David M. Friedland, Chandra P. Belani, Sanjiv S. Agarwala, Michael M. W. Wong, Marwan Fakih, Donald L. Trump, Ruzhi Jin, Sandra Strychor, Michael Vozniak, Monica Troetschel, Ramesh K. Ramanathan
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5058–5064.
https://doi.org/10.1158/1078-0432.CCR-03-0288
Published: 05 August 2004
View article titled, Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors
Open the PDF for Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors in another window
Journal Articles

Combination of 1α,25-Dihydroxyvitamin D3 with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling

Ronald J. Bernardi, Donald L. Trump, Wei-Dong Yu, Terence F. McGuire, Pamela A. Hershberger, Candace S. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (12): 4164–4173.
Published: 01 December 2001
View article titled, Combination of 1α,25-Dihydroxyvitamin D<sub>3</sub> with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: <subtitle>Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling</subtitle>
Open the PDF for Combination of 1α,25-Dihydroxyvitamin D<sub>3</sub> with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: <subtitle>Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling</subtitle> in another window
Journal Articles

Allelic Variants of Aromatase and the Androgen and Estrogen Receptors: Toward a Multigenic Model of Prostate Cancer Risk

Francesmary Modugno, Joel L. Weissfeld, Donald L. Trump, Joseph M. Zmuda, Patrick Shea, Jane A. Cauley, Robert E. Ferrell
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3092–3096.
Published: 01 October 2001
View article titled, Allelic Variants of Aromatase and the Androgen and Estrogen Receptors: <subtitle>Toward a Multigenic Model of Prostate Cancer Risk</subtitle>
Open the PDF for Allelic Variants of Aromatase and the Androgen and Estrogen Receptors: <subtitle>Toward a Multigenic Model of Prostate Cancer Risk</subtitle> in another window
Journal Articles

Calcitriol (1,25-Dihydroxycholecalciferol) Enhances Paclitaxel Antitumor Activity in Vitro and in Vivo and Accelerates Paclitaxel-induced Apoptosis

Pamela A. Hershberger, Wei-Dong Yu, Ruth A. Modzelewski, Robert M. Rueger, Candace S. Johnson, Donald L. Trump
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 1043–1051.
Published: 01 April 2001
View article titled, Calcitriol (1,25-Dihydroxycholecalciferol) Enhances Paclitaxel Antitumor Activity <em>in Vitro</em> and <em>in Vivo</em> and Accelerates Paclitaxel-induced Apoptosis
Open the PDF for Calcitriol (1,25-Dihydroxycholecalciferol) Enhances Paclitaxel Antitumor Activity <em>in Vitro</em> and <em>in Vivo</em> and Accelerates Paclitaxel-induced Apoptosis in another window
Journal Articles

Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole

Qing Zeng, David C. Smith, Todd J. Suscovich, William E. Gooding, Donald L. Trump, Jennifer Rubin Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2245–2251.
Published: 01 June 2000
View article titled, Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole
Open the PDF for Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole in another window
Journal Articles

A Phase I Trial of Calcitriol (1,25-Dihydroxycholecalciferol) in Patients with Advanced Malignancy

David C. Smith, Candace S. Johnson, Catherine C. Freeman, Josephia Muindi, John W. Wilson, Donald L. Trump
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (6): 1339–1345.
Published: 01 June 1999
View article titled, A Phase I Trial of Calcitriol (1,25-Dihydroxycholecalciferol) in Patients with Advanced Malignancy
Open the PDF for A Phase I Trial of Calcitriol (1,25-Dihydroxycholecalciferol) in Patients with Advanced Malignancy in another window